| scholarly article | Q13442814 |
| P2093 | author name string | Jean Bénard | |
| Michel Barrois | |||
| Sétha Douc-Rasy | |||
| David Goldschneider | |||
| Etienne Blanc | |||
| Gilda Raguénez | |||
| Gwenaëlle Le Roux | |||
| Hedi Haddada | |||
| Agnès Legrand | |||
| P433 | issue | Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| neuroblastoma | Q938205 | ||
| P304 | page(s) | 293-301 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of Cell Science | Q1524177 |
| P1476 | title | Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line | |
| P478 | volume | 117 |
| Q36742203 | Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells |
| Q38328604 | DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells |
| Q33710161 | Didymin: an orally active citrus flavonoid for targeting neuroblastoma |
| Q28295846 | E1A activates transcription of p73 and Noxa to induce apoptosis |
| Q53168345 | E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells. |
| Q39655015 | Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity |
| Q35130560 | Expression of C-terminal deleted p53 isoforms in neuroblastoma |
| Q34435420 | Identification of novel neuronal isoforms of the Rho-GEF Trio. |
| Q60313575 | MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines |
| Q37696208 | Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma |
| Q39825701 | PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. |
| Q33209206 | Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells |
| Q37198034 | Role of activating transcription factor 3 on TAp73 stability and apoptosis in paclitaxel-treated cervical cancer cells |
| Q43272233 | Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-a |
| Q36979908 | Therapeutic prospects for p73 and p63: rising from the shadow of p53. |
| Q33391861 | Tumor-specific induction of apoptosis by a p53-reactivating compound. |
| Q36331885 | p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells |
| Q42362115 | p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance |
| Q53625386 | p73 cooperates with Ras in the activation of MAP kinase signaling cascade. |
| Q36798725 | p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells |
Search more.